Stem cell company bit.bio lays off quarter of staffnews2025-03-18T19:38:01+00:00March 18th, 2025|Endpoints News|
Sixteen-year-old dies after receiving Sarepta’s Duchenne therapy Elevidysnews2025-03-18T13:21:46+00:00March 18th, 2025|Endpoints News|
Orca Bio’s T cell therapy may help blood cancer patients avoid transplant issuesnews2025-03-17T15:16:35+00:00March 17th, 2025|Endpoints News|
AstraZeneca to buy cell therapy startup EsoBiotec for $425M upfrontnews2025-03-17T10:33:40+00:00March 17th, 2025|Endpoints News|
RFK Jr. convened roundtable around ways to reduce stem cell regulationnews2025-03-14T15:36:02+00:00March 14th, 2025|Endpoints News|
MeiraGTx partners with cryptic AI startup Hologen to advance Parkinson’s gene therapynews2025-03-13T15:32:22+00:00March 13th, 2025|Endpoints News|
Legend to double Carvykti production as it targets blockbuster status news2025-03-12T11:19:37+00:00March 12th, 2025|Endpoints News|
Bristol Myers buys out cell therapy partner 2seventy bionews2025-03-11T07:13:39+00:00March 11th, 2025|Endpoints News|
Beam shares promising first clinical data on gene editing treatmentnews2025-03-10T15:42:30+00:00March 10th, 2025|Endpoints News|
How bluebird’s buyout offer went from $100M upfront to $29Mnews2025-03-07T18:25:38+00:00March 7th, 2025|Endpoints News|
